HIMS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Hims & Hers Health, Inc. to Contact the Firm Today!

NEW YORK, NY / ACCESS Newswire / August 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS) and certain of its officers. Class Definition This lawsuit seeks to […]

SRPT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sarepta Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / August 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ:SRPT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

Alligator Bioscience Provides Highlights from R&D Event 2025

LUND, SE / ACCESS Newswire / August 20, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, provides key highlights from its R&D event held on 19 August 2025. The event featured presentations from Alligator’s management and scientific leadership, outlining Alligator’s clinical progress, upcoming milestones, and strategic outlook. Key

National Energy Services Reunited Corp. Reports Second Quarter 2025 Financial Results

� Revenue for the quarter ended June 30, 2025, is $327.4 million, growing 8.0% sequentially � Net income for the quarter ended June 30, 2025, is $15.2 million, improving 46.3% on a sequential quarter basis � Adjusted EBITDA (a non-GAAP measure)* for the quarter ended June 30, 2025, is $70.6 million, increasing 13.0% sequentially �

America At Home Study Releases Wave Four Insights: New Data Reveals Housing And Community Fundamentals Are Out Of Step With How Americans Live

From evolving household formations to rising wellness demands, America at Home Study offers data-backed and scalable solutions for a foundationally different housing market SAN DIEGO, CA / ACCESS Newswire / August 20, 2025 / The America at Home Study today released wave four of its groundbreaking consumer research, offering the most comprehensive overview yet of

MainStreetChamber Holdings, Inc. Announces President Tommy Meharey’s Appointment To Board Of Directors

Leadership expansion underscores MSCH’s commitment to strategic growth, brand innovation, and shareholder value LAS VEGAS, NEVADA / ACCESS Newswire / August 20, 2025 / MainStreetChamber Holdings, Inc. (OTC PINK:MSCH), a leading global provider of intellectual property and brand licensing, today announced that company President Tommy Meharey has been appointed to its Board of Directors. The

Honda Establishes New Subsidiary in India for Retail Financing Services<BR />

Honda Motor Co., Ltd. (Honda) today announced the recent establishment of a new company in India, Honda Finance India Private Ltd., ("Honda Finance India") that will offer customers retail sales financing services including loans and lease sales options for Honda products in India. In India, where further growth of the motorcycle and automobile markets is

CENTRESTAGE 10th anniversary set to dazzle in September

CENTRESTAGE, the annual gala event for the Asian fashion industry, takes place from 3 to 6 September 2025 at the Hong Kong Convention and Exhibition Centre (HKCEC). Unveiling a grand celebration of style for its 10th anniversary edition, this year's CENTRESTAGE sees a record participation of some 260 brands from 24 countries and regions. The

AlzeCure Appoints Cecilia Wadell as New Head of Development

STOCKHOLM, SE / ACCESS Newswire / August 20, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer’s disease and pain, has appointed Cecilia Wadell, MScPharm, Ph.D., as Head of Development. She will be part of AlzeCure’s management team. Her predecessor,

Scroll to Top